Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25488749.
- Also identified by DOI 10.1158/0008-5472.CAN-14-1008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm associated with asbestos exposure. Although previous studies based on candidate gene approaches have identified important common somatic mutations in MPM, these studies have focused on small sets of genes and have provided a limited view of the genetic alterations underlying this disease. Here, we performed whole-exome sequencing on DNA from 22 MPMs and matched blood samples, and identified 517 somatic mutations across 490 mutated genes. Integrative analysis of mutations and somatic copy-number alterations revealed frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1. Our study presents the first unbiased view of the genomic basis of MPM.
Medical subject headings
- Cullin Proteins
- Cyclin-Dependent Kinase Inhibitor p16
- Mesothelioma
- Neurofibromin 2
- Pleural Neoplasms
- Tumor Suppressor Proteins
- Ubiquitin Thiolesterase